Medicine guide

ALYMSYS

As listed in the register: ALYMSYS 25 mg/mL, solution à diluer pour perfusion

25 mg · solution à diluer pour perfusion

  • Prescription only
Active substance
Bévacizumab
Made by
MABXIENCE RESEARCH (ESPAGNE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byMABXIENCE RESEARCH (ESPAGNE)
Active substanceBévacizumab
Strength25 mg
Formsolution à diluer pour perfusion
Routeintraveineuse
Dispensing (as stated by the register)réservé à l'usage HOSPITALIER · prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE · liste I · prescription réservée aux médecins compétents en CANCEROLOGIE
MarketedNo — authorised but not currently marketed, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/20/1509
Name in the registerALYMSYS 25 mg/mL, solution à diluer pour perfusion
Packs1 flacon(s) de 4 ml · 1 flacon(s) de 16 ml
CIS64586704
CIP133400955080497
CIP133400955080503

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.